Dube Eric M Insider Trades

Insider Trading History

Track insider trading activity for Dube Eric M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $19.6M 432,886 shares
Last Trade
May 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$989k 22,500 shares
$43.95
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $2.03M 45,000 shares
Last Trade
May 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.02M 45,000 shares
$44.91
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $20.6M 455,386 shares
Last Trade
May 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.01M 22,500 shares
$44.91
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $1.02M 22,500 shares
Last Trade
May 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.01M 22,500 shares
$44.91
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $19.9M 440,071 shares
Last Trade
Apr 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.63M 64,000 shares
$41.09
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $22.5M 496,886 shares
Last Trade
Apr 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.96M 64,000 shares
$30.70
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $0 0 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.89M 60,000 shares
$31.42
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $22.3M 492,886 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.89M 60,000 shares
$31.42
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $20.7M 457,984 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.86M 60,000 shares
$30.93
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $2.71M 60,000 shares
Last Trade
Feb 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.82M 60,000 shares
$30.39
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $22.3M 492,886 shares
Last Trade
Feb 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.82M 60,000 shares
$30.39
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $19.6M 432,886 shares
Last Trade
Feb 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.81M 60,000 shares
$30.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $21.1M 466,521 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.23M 100,087 shares
$32.28
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $24.1M 532,973 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13M 417,400 shares
$31.09
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $5.42M 120,000 shares
Last Trade
Jan 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.54M 51,865 shares
$29.71
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $18.9M 419,173 shares
Last Trade
Jan 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.56M 51,865 shares
$30.10
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $21.3M 471,038 shares
Last Trade
Jan 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.54M 51,865 shares
$29.71
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $18.9M 419,173 shares
Last Trade
Jan 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$244k 8,135 shares
$30.01
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $19.3M 427,308 shares
Last Trade
Jan 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$239k 8,135 shares
$29.44
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
CHIEF EXECUTIVE OFFICER
Holding Value $7.77M 171,865 shares
Last Trade
Jan 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$239k 8,135 shares
$29.44
$45.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up